The role of community acceptance over time for costs of HIV and STI prevention interventions: Analysis of the Masaka Intervention Trial, Uganda, 1996-1999

Sexually Transmitted Diseases

Volumn 33, Issue 10 SUPPL., 2006, Pages

  Terris Prestholt, Fern ^a   Kumaranayake, Lilani ^a   Foster, Susan ^b   Kamali, Anatoli ^c   Kinsman, John ^d   Basajja, Vincent ^c   Nalweyso, Nora ^e   Quigley, Maria ^a   Kengeya Kayondo, Jane ^f   Whitworth, James ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b BOSTON UNIVERSITY   (United States)

^c MEDICAL RESEARCH COUNCIL   (Uganda)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONDOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COUNSELING; HEALTH ECONOMICS; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; UGANDA;

ADVERTISING; COMMUNITY HEALTH AIDES; CONDOMS; COSTS AND COST ANALYSIS; HIV INFECTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS; REFERRAL AND CONSULTATION; SCHOOLS; SEXUALLY TRANSMITTED DISEASES; SOCIAL WELFARE; UGANDA; VOLUNTARY HEALTH AGENCIES;

EID: 33749023573     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000175389.10289.ba     Document Type: Article

References (29)

1. Haddix A, Corso P, Gorsky RD. Costs. In: Haddix A, Teutsch S, Corso P, ed. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. Oxford: Oxford University Press; 2003:53-76.
2. Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 2002; 359:1635-1642.
3. Kumaranayake L, Watts C. Economic costs of HIV/AIDS prevention activities in sub-Saharan Africa. AIDS 2000; 14:S239-252.
4. Walker D. Cost and cost-effectiveness of HIV prevention activities in sub-Saharan Africa: a systematic review of the evidence. Health Policy Plan 2003; 18:4-17.
5. Kumaranayake L, Kurowski C, Conteh L. Costs of scaling up priority health interventions in low-income and selected middle-income countries: methodology and estimates. CMH Working Paper No WG5:18: Commission on Macroeconomics and Health; 2001. http:// www.cmhealth.org/docs/wg5_paper19.pdf.
6. Kumaranayake L, Watts C. Costs of Scaling HIV Program Activities to a National Level for Sub-Saharan Africa. World Bank: Washington, DC; 2000.
7. Foster S, McFarland D, John A. Measles. In: Jamison D, Mosley W, Measham A, et al., eds. Disease Control Priorities in Developing Countries. New York: Oxford University Press; 1993:161-187.
8. Muirhead D, Kumaranayake L, Watts C. Economically Evaluating the 4th Soul City Series: Costs and Impact on HIV/AIDS and Violence against Women. Johannesburg: Institute for Health and Development Communications; 2002.
9. Terris-Prestholt F, Kumaranayake L, Ginwalla R, et al. The cost-effectiveness of the Zambian ProTEST project: integrating VCT with tuberculosis activities. Abstract nr. WeOr1287. 14th International AIDS Conference. Barcelona; 2002.
10. Hanson K, Kumaranayake L, Terris-Prestholt F. Cost-effectiveness of Social Marketing: Background Paper for UNAIDS/WHO/UNFPA: Forum on Social Marketing. London School of Hygiene and Tropical Medicine; 2000.
11. Terris-Prestholt F, Kumaranayake L, Obasi A, et al. Costs of an adolescent sexual health programme in Mwanza, Tanzania: pilot costs and estimates for distrect wide implementation. Abstract nr. TuPeC4956. 15th International AIDS Conference; 2004.
12. Sweat M, Gregorich S, Sangiwa G, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000; 356:113-121.
13. Stallworthy G, Meekers D. An analysis of unit costs in selected condom social marketing programs, 1990-1996. Soc Mar Q 1996; 6:9-16.
14. Terris-Prestholt F, Nowitz D, Kumaranayake L, et al. Launching Microbicides: How Important Is Promotion? Microbicides 2004. London; 2004.
15. United Nations Population Division. World Population Prospects: The 2002 revision. 2002. http://www.un.org/esa/population/publications/ wpp2002/wpp2002annextables.pdf.
16. Kamali A, Kinsman J, Nalweyiso N, et al. A community randomized controlled trial to investigate impact of improved STD management and behavioural interventions on HIV incidence in rural Masaka, Uganda: trial design, methods and baseline findings. Trop Med Int Health 2002; 7:1053-1063.
17. Kamali A, Quigley M, Nakiyingi J, et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 2003; 361:645-652.
18. Kinsman J, Kamali A, Kanyesigye E, et al. Quantitative process evaluation of a community-based HIV/AIDS behavioural intervention in rural Uganda. Health Educ Res 2002; 17:253-265.
19. Kinsman J, Harrison S, Kengaya-Kayondo J, et al. Implementation of a comprehensive AIDS education programme for schools in Masaka District, Uganda. AIDS Care 1999; 11:591-601.
20. Kinsman J, Nakiyingi J, Kamali A, et al. Evaluation of a comprehensive school-based AIDS education programme in rural Masaka, Uganda. Health Educ Res 2001; 16:85-100.
21. Quigley M, Kamali A, Kinsman J, et al. The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda. AIDS 2004; 18:2055-2063.
22. Drummond M. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford Medical Publications; 1997.
23. Kumaranayake L. The real and the nominal? making inflationary adjustments to cost and other economic data. Health Policy Plan 2000; 15:230-234.
24. Kumaranayake L, Watts C, Vickerman P, Terris-Prestholt F. Linking costs and effectiveness: dynamic challenges for HIV prevention. In: Roberts J, Archibald K, eds. The Economics of Infectious Diseases. Oxford: Oxford University Press; in press.
25. Soderlund N, Lavis J, Broomberg J, Mills A. The costs of HIV prevention strategies in developing countries. Bull World Health Organ 1993; 71:595-604.
26. Forsythe S, Mangkalopakorn C, Chitwarakorn A, Masvichian N. Cost of providing sexually transmitted disease services in Bangkok. AIDS 1998; 12:S73-S80.
27. Gilson L, Mkanje R, Grosskurth H, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 1997; 350:1805-1809.
28. Terris-Prestholt F, Delany-Moretlwe S, Vickerman P, et al. Are targeted HIV-prevention activities cost-effective in high prevalence settings? results from Johannesburg, South Africa. IHEA 4th World Congress. 15-18 June 2003. San Francisco; 2003.
29. Watts C, Goodman H. Resource Allocation for HIV Prevention. Geneva: WHO/GPA; 1995.